The collaboration aims to enhance the accuracy of physics-based methods with AI models for optimising small molecule medicine discovery and development
Extended lab space for product development, customer demos, and training
Label updates reflect growing body of real-world evidence and regulatory confidence in the safety profile of the class of CD19- and BCMA-directed autologous CAR T cell therapies, reinforcing efforts to increase equitable access
The approval is based on a comprehensive package of analytical, nonclinical, and clinical data
Viatel bioresorbable polymers are increasingly used in dental and orthopedic implants
TEVIMBRA is a uniquely designed anti-PD-1 monoclonal antibody developed by BeiGene (now BeOne Medicines)
Innovative agents highlight growth of targeted protein degradation platform and BMS' leadership in innovative cancer therapies
Dilip Shanghvi to continue as the Executive Chairman of the Board
This project builds on a previous joint funding agreement between CARBOGEN AMCIS and the same customer in April 2021
BioNTech and Bristol Myers Squibb will jointly execute a broad clinical development program to evaluate and advance BNT327 across numerous solid tumor types
Subscribe To Our Newsletter & Stay Updated
